New York, NY -- (SBWIRE) -- 01/15/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Siliconware Precision Industries (ADR) (NASDAQ:SPIL), Majesco Entertainment Co (NASDAQ:COOL), Lexicon Pharmaceuticals, Inc (NASDAQ:LXRX), FreeSeas Inc (NASDAQ:FREE)
Siliconware Precision Industries (ADR) (NASDAQ:SPIL) showed a volume of 1.41 million shares by the end of last trade whereas the average volume of the stock remained 367,089 shares. The stock opened the session at $6.13 but then moved to $6.16. At that price, the stock showed a positive performance of 0.49%. Siliconware Precision Industries Co., Ltd. is principally engaged in the provision of semiconductor packaging and testing services. The Company operates its businesses through packaging services, which deals with ball grid array (BGA) integrated circuits (ICs), flip-chip BGA ICs and other IC products; bumping services, which offers 8- and 12-inch wafer bumping; testing services,
Will SPIL Continue To Move Higher? Find Out Here
Majesco Entertainment Co (NASDAQ:COOL) opened the session at $0.73 and closed the session at $0.720. The stock showed a positive performance of 1.55% in previous trading session. Majesco Entertainment Company is a provider of video game products primarily for the family oriented, casual-game consumer. he Company sells its products primarily to retail chains, specialty retail stores, video game rental outlets and distributors. It publishes video games for almost all current generation interactive entertainment hardware platforms,
For How Long COOL will fight for Profitability? Read This Trend Analysis report
Lexicon Pharmaceuticals, Inc (NASDAQ:LXRX) opened the session at $1.92 and closed the session at $2.01. The stock showed a positive performance of 3.08% in previous trading session. Traded with volume of 1.38 million shares in the prior session and the average volume of the stock remained 1.49 million shares. The beta of the stock remained 2.08. Lexicon Pharmaceuticals, Inc. (Lexicon Pharmaceuticals) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Lexicon Pharmaceuticals uses its gene knockout technologies and an integrated platform of medical technologies to study the physiological and behavioral functions of almost 5,000 genes in mice and assessed the utility of the proteins encoded by the corresponding human genes as drug targets.
Why Should Investors Buy LXRX After The Recent Gain? Just Go Here and Find Out
FreeSeas Inc (NASDAQ:FREE) the stock advanced 0.86% and finished the session at $1.75. Traded with volume of 1.38 million shares in the prior session and the average volume of the stock remained 3.84 million shares. The beta of the stock remained 3.49. FreeSeas Inc. (FreeSeas) is a parent holding company of its ship-owning companies. The Company’s fleet consists of six Handysize vessels and one Handymax vessel that carry a variety of drybulk commodities, including iron ore, grain and coal, which are referred to as bulks, as well as bauxite, phosphate, fertilizers, steel products, cement, sugar and rice, or minor bulks.
Will FREE Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)